Open Nature Cough Drops recalled due to subpotent menthol content
Bestco LLC is recalling Open Nature Cough Drops (Menthol flavor) due to insufficient menthol content. Products may not be effective as labeled.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: This is an FDA Class III recall involving a subpotency issue with no reported illnesses, injuries, or safety hazards. The risk is efficacy-related, not safety-related, consistent with typical Class III classification scoring.
Plain-English summary
Open Nature Cough Drops Menthol-Cough Suppressant/Oral Anesthetic Peppermint Naturally Flavored are being recalled due to subpotent menthol content. Testing found that the menthol active ingredient failed to meet quality specifications after three months of storage at room temperature.
Approximately 2038 bags were distributed in California, Idaho, Pennsylvania, and Oklahoma. The affected lot is #100010885, with an expiration date of November 2024. Consumers who have purchased this product should discard it or return it to the point of purchase.
No illnesses or injuries have been reported. However, the product may not provide the intended cough-suppression effect due to the substandard menthol content.
The recalled product
- Product
- Open Nature Cough Drops Menthol-Cough Suppressant/Oral Anesthetic Peppermint Naturally Flavored, packaged in Bags of 30 lozenges, Distributed By Lucerne Foods, Inc. P.O. Box 99, Pleasanton, CA 96566-0009, UPC 0 79893 41266 5
- Manufacturer
- Bestco LLC
- Category
- Drug — Cough Suppressant
- Hazard
- subpotency
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 100010885
- Exp 11/2024
Distribution
Distributed in 4 states:
- CA
- ID
- OK
- PA
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27